Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is scheduled to exhibit 4 abstracts at ...